Loading...

Benchmark Holdings plc

BMK.LLSE
Healthcare
Drug Manufacturers - Specialty & Generic
£20.95
£-1.25(-5.63%)

Benchmark Holdings plc (BMK.L) Financial Performance & Income Statement Overview

Explore the financials of Benchmark Holdings plc (BMK.L), including yearly and quarterly data on income, cash flow, and balance sheets.

Revenue Growth
-46.68%
46.68%
Operating Income Growth
-567.78%
567.78%
Net Income Growth
-70.50%
70.50%
Operating Cash Flow Growth
-89.98%
89.98%
Operating Margin
-79.09%
79.09%
Gross Margin
47.79%
47.79%
Net Profit Margin
90.60%
90.60%
ROE
18.62%
18.62%
ROIC
-12.62%
12.62%

Benchmark Holdings plc (BMK.L) Income Statement & Financial Overview

Access detailed annual and quarterly income data for Benchmark Holdings plc BMK.L financial performance.

MetricQ1 2025Q4 2024Q3 2024Q2 2024
Revenue$17.72M-$20.55M$30.69M$39.75M
Cost of Revenue$10.15M-$9.63M$15.07M$26.41M
Gross Profit$7.58M-$10.92M$15.62M$13.35M
Gross Profit Ratio$0.43$0.53$0.51$0.34
R&D Expenses$567000.00-$2.02M$1.41M$1.54M
SG&A Expenses$0.00$0.00$0.00$9.86M
Operating Expenses$13.62M$14.37M$22.11M$11.40M
Total Costs & Expenses$23.77M$4.74M$37.18M$37.81M
Interest Income$18000.00$0.00$65000.00$76000.00
Interest Expense$2.31M$0.00$2.92M$2.71M
Depreciation & Amortization$5.95M$22.37M$8.42M$7.54M
EBITDA$916000.00-$6.54M$1.92M$9.48M
EBITDA Ratio$0.05$0.32$0.06$0.24
Operating Income-$6.04M-$25.29M-$6.50M$1.94M
Operating Income Ratio-$0.34$1.23-$0.21$0.05
Other Income/Expenses (Net)-$1.02M-$3.35M-$2.92M-$3.28M
Income Before Tax-$7.07M-$28.64M-$9.42M-$1.34M
Income Before Tax Ratio-$0.40$1.39-$0.31-$0.03
Income Tax Expense$213000.00-$3.08M$529000.00$477000.00
Net Income-$9.93M-$20.60M-$9.91M-$1.32M
Net Income Ratio-$0.56$1.003-$0.32-$0.03
EPS-$0.01-$0.03-$0.01-$0.002
Diluted EPS$0.00-$0.03-$0.01-$0.002
Weighted Avg Shares Outstanding$739.78M$739.78M$739.71M$739.46M
Weighted Avg Shares Outstanding (Diluted)$0.00$739.78M$739.71M$739.46M

Over the last four quarters, Benchmark Holdings plc's revenue moved from $39.75M in Q2 2024 to $17.72M in Q1 2025. Operating income in Q1 2025 was -$6.04M, with a strong operating margin of -34%. Despite fluctuations in R&D and SG&A expenses, EBITDA for Benchmark Holdings plc remained robust at $916000.00, reflecting operational efficiency. Net income rose to -$9.93M, with an EPS of -$0.01. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.

Unlock 25+ Years of Financial Data

Get access to extended historical data, advanced metrics, and more with our premium plan

Frequently Asked Questions

;